Carlos Fernández-Hernando1, Yajaira Suárez. 1. Program in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, Department of Pathology and the Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, USA.
Abstract
PURPOSE OF REVIEW: Since the first discovery of Angiopoetin-like 4 (ANGPTL4) in 2000, the involvement of ANGPTL4 in different aspects of lipid metabolism and vascular biology has emerged as an important research field. In this review, we summarize the fundamental roles of ANGPTL4 in regulating metabolic and nonmetabolic functions and their implication in lipid metabolism and with several aspects of vascular function and dysfunction. RECENT FINDINGS: ANGPTL4 is a secreted glycoprotein with a physiological role in lipid metabolism and a predominant expression in adipose tissue and liver. ANGPTL4 inhibits the activity of lipoprotein lipase and thereby promotes an increase in circulating triglyceride levels. Therefore, ANGPTL4 has been highly scrutinized as a potential therapeutic target. Further involvement of ANGPTL4 has been shown to occur in tumorigenesis, angiogenesis, vascular permeability and stem cell regulation, which opens new opportunities of using ANGPTL4 as potential therapeutic targets for other pathophysiological conditions. SUMMARY: Further determination of ANGPTL4 regulatory circuits and defining specific molecular events that mediate its biological effects remain key to future ANGPTL4-based therapeutic applications in different disease settings. Many new and unanticipated roles of ANGPTL4 in the control of cell-specific functions will assist clinicians and researchers in developing potential therapeutic applications.
PURPOSE OF REVIEW: Since the first discovery of Angiopoetin-like 4 (ANGPTL4) in 2000, the involvement of ANGPTL4 in different aspects of lipid metabolism and vascular biology has emerged as an important research field. In this review, we summarize the fundamental roles of ANGPTL4 in regulating metabolic and nonmetabolic functions and their implication in lipid metabolism and with several aspects of vascular function and dysfunction. RECENT FINDINGS: ANGPTL4 is a secreted glycoprotein with a physiological role in lipid metabolism and a predominant expression in adipose tissue and liver. ANGPTL4 inhibits the activity of lipoprotein lipase and thereby promotes an increase in circulating triglyceride levels. Therefore, ANGPTL4 has been highly scrutinized as a potential therapeutic target. Further involvement of ANGPTL4 has been shown to occur in tumorigenesis, angiogenesis, vascular permeability and stem cell regulation, which opens new opportunities of using ANGPTL4 as potential therapeutic targets for other pathophysiological conditions. SUMMARY: Further determination of ANGPTL4 regulatory circuits and defining specific molecular events that mediate its biological effects remain key to future ANGPTL4-based therapeutic applications in different disease settings. Many new and unanticipated roles of ANGPTL4 in the control of cell-specific functions will assist clinicians and researchers in developing potential therapeutic applications.
Authors: Haruka Okamoto; Katie Cavino; Erqian Na; Elizabeth Krumm; Steven Kim; Panayiotis E Stevis; Joyce Harp; Andrew J Murphy; George D Yancopoulos; Jesper Gromada Journal: Proc Natl Acad Sci U S A Date: 2017-01-31 Impact factor: 11.205
Authors: L M Hermann; M Pinkerton; K Jennings; L Yang; A Grom; D Sowders; S Kersten; D P Witte; R Hirsch; S Thornton Journal: Clin Immunol Date: 2005-04 Impact factor: 3.969
Authors: Chuchun L Chang; Itsaso Garcia-Arcos; Rakel Nyrén; Gunilla Olivecrona; Ji Young Kim; Yunying Hu; Rishi R Agrawal; Andrew J Murphy; Ira J Goldberg; Richard J Deckelbaum Journal: Arterioscler Thromb Vasc Biol Date: 2018-01-25 Impact factor: 8.311
Authors: Suneil K Koliwad; Taiyi Kuo; Lauren E Shipp; Nora E Gray; Fredrik Backhed; Alex Yick-Lun So; Robert V Farese; Jen-Chywan Wang Journal: J Biol Chem Date: 2009-07-23 Impact factor: 5.157
Authors: Melissa C Smart-Halajko; Alyson Kelley-Hedgepeth; Maria Claudia Montefusco; Jackie A Cooper; Alan Kopin; Jeanne M McCaffrey; Ashok Balasubramanyam; Henry J Pownall; David M Nathan; Inga Peter; Philippa J Talmud; Gordon S Huggins Journal: BMC Med Genet Date: 2011-06-29 Impact factor: 2.103